Iwaki Co., Ltd.
Financial Results Explanation Material for Fiscal Year Ending March 2026
The sales revenue for the fiscal year ending March 2026 is 47,692 million yen (up 1,929 million yen YoY), operating profit is 5,924 million yen (up 79 million yen YoY), and net income is 4,835 million yen (up 367 million yen YoY). Sales exceeded the previous year, and profits also increased. The segments performed well, particularly in medical devices and semiconductor-related areas. Continued growth is expected.
Key Figures
- Sales Revenue: 47,692 million yen (up 4.2% YoY)
- Operating Profit: 5,924 million yen (up 1.4% YoY)
- Net Income: 4,835 million yen (up 8.2% YoY)
AI要約
Financial Performance Overview
Iwaki Co., Ltd. achieved net sales of 47,692 million yen (up 4.2% YoY), operating profit of 5,924 million yen (up 1.4%), and net income of 4,835 million yen (up 8.2%) for the fiscal year ending March 2026. The increase in sales was mainly driven by strong performances in medical devices and semiconductor sectors, with profits steadily trending upward. Segment-wise, sales of medical devices and electronic components increased, pushing overall performance. Going forward, the company aims to continue growth through the introduction of new products and expanding overseas operations.
Future Outlook and Strategy
Iwaki will continue to focus on expanding its medical device and semiconductor-related businesses, planning to introduce new products and broaden its overseas market presence. Especially in Asia and North America, sales are expected to further increase. The company will also promote cost management and efficiency improvements to enhance profit margins. In the medium to long term, efforts will be made toward developing environmentally friendly products and next-generation technologies to achieve sustainable growth.
Iwaki Co., Ltd.
Company overview · Stock price · Financial data · All IR
